logo-loader
viewGenetic Technologies

Genetic Technologies transitioning to an e-commerce platform

The company provides a risk assessment test for non-hereditary breast cancer.

A breast examination
Genetic has shifted to a patient self-pay program

Genetic Technologies Limited (ASX:GTG) is planning to transition the commercialisation of its BREVAGenplus test to an e-commerce based solution.

Genetic is a molecular diagnostics company specialising in cancer genomics, and provides BREVAGenplus®, a clinically validated risk assessment test for non-hereditary breast cancer.

Under the new program, consumers will be able to initiate the testing by accessing the consumer initiated testing (CIT) platform via the company’s website www.brevagenplus.com.

Genetic’s recent shift to a patient self-pay program coupled with the on-going operational strategic review has served as catalysts to transform the commercial program into an ecommerce system.

CIT provides testing under the guidance and management of a remote physician using guideline driven protocols.

It ensures that a two-way patient physician relationship is established, results are interpreted correctly and abnormal results are flagged responsibly and communicated in a way to drive action.

A CIT platform, complemented by direct to consumer advertising, can reach two primary audiences through various channels and mediums.

First, the patient that qualifies for the product may be reached through multiple promotions and second, the healthcare provider that focuses on women’s health and breast health.

Under the refined commercial program, a BREVAGenplus dedicated staff member will be available telephonically to address product specification queries and provide more details about the test.

Quick facts: Genetic Technologies

Price: 0.005 AUD

ASX:GTG
Market: ASX
Market Cap: $15.74 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Viva Gold kicking off PEA of Tonopah gold project in Nevada

Viva Gold Corp (CVE:VAU) (OTCBB: VAUCF) CEO James Hesketh tells Proactive the Nevada-based gold exploration and development company will begin its Preliminary Economic Assessment of its Tonopah gold project. Hesketh says that based on positive preliminary metallurgical results from its fall...

13 hours, 5 minutes ago

2 min read